Designers: SHL Medical Design Team, SHL Medical, Zug, Switzerland
Manufacturer: Innovation Zed, Dublin, Ireland
The 2020 National Diabetes Statistics Report published by the US Centers for Disease Control and Prevention indicates a total of 34.2 million Americans currently living with diabetes.
On the other hand, the International Diabetes Federation estimates that around 700 million adults worldwide will have diabetes by 2045.
Diabetes is a collection of diseases characterized by elevated blood glucose. For its sufferers, living with this disease requires lifestyle modification as well as insulin management through medications required to be administered in precise doses and timing.
With the current global pandemic, secondary aid devices compatible with connected technologies could provide additional values for patients with diabetes home treatment regimen.
The InsulCheck Connect is a reusable and compact add-on device to insulin pens. It serves as a secondary aid in diabetes management by automatically recording information about the timing of insulin injections.
Its design includes a large screen indicating the status of the device and a mounting mechanism to clip the device onto a pen.
When the device is properly mounted on a pen, an animation indicating successful mounting is displayed on the screen.
The device features a patented mode of detection based on an optical sensor that recognizes dose-knob movement at the end of injection.
When the patient injects, the dose- knob dials in and the device automatically starts a timing function. This timer will count up, indicating time since previous injection.
Using Bluetooth technology, data from the device can be shared with connected apps. Featuring a customizable sleeve, the device can accommodate a variety of pen-based injection treatments, further supporting patient disease management.
